» Articles » PMID: 19626189

Biopsy of Tumors of the Musculoskeletal System

Overview
Date 2009 Jul 24
PMID 19626189
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Malignant tumors of the musculoskeletal system are rare, and their symptoms are non-specific. The diagnosis of primary malignant tumors of bone or soft tissue by tissue biopsy is necessary before multimodal treatment with chemo- and/or radiotherapy and resection can be provided. These biopsies are straightforward surgical procedures; they must, however, be performed according to the guidelines if high rates of error and complications are to be avoided.

Methods: Selective literature review.

Results: Biopsies are either incisional or excisional. There are guidelines for the performance of both kinds. The biopsy channel is inevitably contaminated with tumor cells and thus must be completely removed together with the tumor. Excisional biopsies are indicated only for the histopathological diagnosis of small (< 5 cm), epifascial soft-tissue tumors and small, slowly growing bony tumors that are considered most likely to be benign. If in doubt, an incision biopsy should be performed.

Discussion: The complication rate of tumor biopsies is known to be higher when they are performed in an institution without extensive experience in the treatment of sarcoma. Thus, patients with musculoskeletal tumors that are suspected of being malignant should be referred to a suitable tumor center for biopsy.

Citing Articles

Synthesis and Evaluation of Thiazolyl-indole-2-carboxamide Derivatives as Potent Multitarget Anticancer Agents.

Saadan N, Ahmed W, Kadi A, Al-Mutairi M, Al-Wabli R, Rahman A ACS Omega. 2024; 9(40):41944-41967.

PMID: 39398118 PMC: 11465279. DOI: 10.1021/acsomega.4c06889.


Distal Dorsal Thumb Mass: Giant Cell Tumor of the Tendon Sheath in an Unusual Location.

Brummund D, Chang A Cureus. 2023; 15(7):e41532.

PMID: 37551250 PMC: 10404461. DOI: 10.7759/cureus.41532.


The Diagnosis and Treatment of Osteosarcoma and Ewing's Sarcoma in Children and Adolescents.

Zarghooni K, Bratke G, Landgraf P, Simon T, Maintz D, Eysel P Dtsch Arztebl Int. 2023; 120(24):405-412.

PMID: 37097079 PMC: 10437036. DOI: 10.3238/arztebl.m2023.0079.


Surgical Treatment of Bone Sarcoma.

Blasius F, Delbruck H, Hildebrand F, Hofmann U Cancers (Basel). 2022; 14(11).

PMID: 35681674 PMC: 9179414. DOI: 10.3390/cancers14112694.


Lipomatous Tumors: A Comparison of MRI-Reported Diagnosis with Histological Diagnosis.

Ballhause T, Korthaus A, Jahnke M, Frosch K, Yamamura J, Dust T Diagnostics (Basel). 2022; 12(5).

PMID: 35626435 PMC: 9141562. DOI: 10.3390/diagnostics12051281.


References
1.
Brouns F, Stas M, De Wever I . Delay in diagnosis of soft tissue sarcomas. Eur J Surg Oncol. 2003; 29(5):440-5. DOI: 10.1016/s0748-7983(03)00006-4. View

2.
Nijhuis P, Schaapveld M, Otter R, Hoekstra H . Soft tissue sarcoma--compliance with guidelines. Cancer. 2001; 91(11):2186-95. DOI: 10.1002/1097-0142(20010601)91:11<2186::aid-cncr1248>3.0.co;2-3. View

3.
Gustafson P, Dreinhofer K, Rydholm A . Soft tissue sarcoma should be treated at a tumor center. A comparison of quality of surgery in 375 patients. Acta Orthop Scand. 1994; 65(1):47-50. DOI: 10.3109/17453679408993717. View

4.
STOKER D, Cobb J, PRINGLE J . Needle biopsy of musculoskeletal lesions. A review of 208 procedures. J Bone Joint Surg Br. 1991; 73(3):498-500. DOI: 10.1302/0301-620X.73B3.1670457. View

5.
Ray-Coquard I, Ranchere-Vince D, Thiesse P, Ghesquieres H, Biron P, Sunyach M . Evaluation of core needle biopsy as a substitute to open biopsy in the diagnosis of soft-tissue masses. Eur J Cancer. 2003; 39(14):2021-5. DOI: 10.1016/s0959-8049(03)00430-1. View